在没有肝功能障碍的老年患者中,氨酸诱导的高氨性脑病变成功用利沃卡尼丁治疗
Masahiko Kaneko1, Hisaharu Shikata1, Hisafumi Kihara1
1Department of Internal Medicine and Hematology, Uwajima City Hospital, Uwajima, JPN.
瓦尔酸盐治疗可能会导致由于卡尼耗尽而引起的高氨性脑病变. 及时的勒沃卡尼丁治疗有效地管理了这种严重的副作用在患有发作疾病的患者.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
- 生物化学 生物化学
背景情况:
- 酸是一种广泛使用的抗药物.
- 长期使用烯酸盐可能会导致肉素耗尽.
- 卡尼丁缺乏与高血性脑病症有关.
研究的目的:
- 报告一种氨酸诱导的高氨性脑病变病例.
- 为了突出卡尼丁缺乏在这种情况中的作用.
- 为了强调勒沃卡尼丁治疗的疗效.
主要方法:
- 一位患有发作障碍的老年男性患者的病例报告.
- 意识受损和厌食症的临床表现.
- 实验室调查显示氨含量升高,肉含量降低.
主要成果:
- 瓦尔酸诱导的高血性脑病变的诊断得到证实.
- 通过停止氨酸,补充勒沃卡尼丁和分支链氨基酸输液成功管理.
- 实现了症状的持久解决.
结论:
- 氨酸诱导的高氨血性脑病变是一种关键的诊断,应考虑在长期接受氨酸治疗的患者中呈现脑病变.
- 卡尼丁缺乏是关键的机制.
- 早期启动勒沃卡尼丁对于有效的管理和患者康复至关重要.
更多相关视频
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Poisoning: Treatment Strategies
Hepatic Encephalopathy
